TRAN TRUONG: Open Payments
NPI 1437889227 · ASTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,312 in 216 payments from 31 companies in 2025. Trend: 2023 $3,170 · 2024 $3,461 · 2025 $4,312
Food & beverage: $4,312
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 24 | $545 |
| AstraZeneca Pharmaceuticals LP | 19 | $442 |
| PFIZER INC. | 26 | $420 |
| GlaxoSmithKline, LLC. | 14 | $321 |
| ABBVIE INC. | 20 | $283 |
| Lilly USA, LLC | 5 | $216 |
| Otsuka America Pharmaceutical, Inc. | 11 | $206 |
| Exact Sciences Corporation | 11 | $187 |
| Axsome Therapeutics, Inc. | 7 | $163 |
| Astellas Pharma US Inc | 10 | $148 |
Products named: Wegovy, TRELEGY ELLIPTA, REXULTI, AIRSUPRA, ELIQUIS, Auvelity, BREZTRI, PREVNAR 20.
Industry payments across PA — which companies pay providers there.
